What's on at Auscap
Check out our latest newsletter, webinar and upcoming events
Auscap Newsletter February 2024
The Fund returned 0.6% net of fees during January 2024. This compares with the All Ordinaries Accumulation Index return of 1.1%
Auscap Newsletter January 2024
Auscap’s views discussed below are based on factual information available to us at the date of publication of this newsletter.
Auscap Newsletter December 2023
The Fund returned 5.8% net of fees during November 2023. The All Ordinaries Accumulation Index returned 5.2% during that period.
Auscap Newsletter November 2023
The Fund returned negative 6.1% net of fees during October 2023. The All Ordinaries Accumulation Index returned negative 3.9% during that period
Auscap Investor Webinar – November 2023 – Introducing The Auscap Ex-20 Australian Equities Fund
Please ensure that you take a moment to read the disclaimers in the presentation.
Calcutta 2024: Top fundies name 14 stock picks for the running of the Golden Bull – Livewire, 30 October 2023
And only one of this year's stock picks is a "short".
Mercer League Tables Reveal Fund Leaders – The Australian, 25 October 2023
The Australian fund manager investment rankings reveal some consistent outperformers in a tough environment.
‘Quality growth’: The ASX lithium stock with an ‘impressive’ record – The Motley Fool, 24 October 2023
If you want to invest in a miner that already has mass production capabilities, Auscap experts reckon this could be the investment for you.
Auscap Newsletter October 2023
Auscap’s views discussed below are based on factual information available to us at the date of publication of this newsletter.
Auscap Newsletter September 2023
The Fund returned 5.2% net of fees during August 2023. The All Ordinaries Accumulation Index returned negative 0.7% during that period
Tim Carleton’s Auscap fronts up with new long-only fund – AFR, 11 September 2023
Australia’s mid-cap fund space is about to get busier.
Buy Hold Sell: 3 shocking results (and 2 stocks flying under the radar)
In this episode, IML's Michael O'Neill and Auscap's Will Mumford analyse some of the market's most controversial stocks.
